Apple Inc. (NASDAQ:AAPL) recently hired another medical sensor expert, which adds more fuel to iWatch rumors. The tech giant’s latest hire is Marcelo Malini Lamego, the former CTO of Cercaor.
Apple’s latest hire has abundance of medical tech experience
Last month, Lemego started working for Apple Inc. (NASDAQ:AAPL) as a researcher and developer for Apple. He is credited with creating over 70 patent applications and patents in a number of categories. He also wrote over 30 peer-reviewed articles on a variety of technology topics including adaptive systems and neural networks.
GrizzlyRock Value Partners was up 16.6% for the first quarter, compared to the S&P 500's 5.77% gain and the Russell 2000's 12.44% return. GrizzlyRock's long return was 22.3% gross, while its short return was -2.9% gross. Compared to the Russell 2000, the fund's long portfolio delivered alpha of 10.8%, while its short portfolio delivered alpha Read More
It’s Lamego’s experience that makes him a desirable employee for Apple. He was the leading scientist behind Masimo’s “Rainbow Technology”. This tool is used as a noninvasive monitoring tool which makes assessments on multiple blood constituents and physiologic parameters. This tool is placed on the user’s fingertip to measure oxygen content, hemoglobin, methemoglobin, carboxyhemoglobin, and more. This particular gadget utilizes over seven different wavelengths of light to obtain data on blood constituent based on light absorption.
The other recent hire
Apple Inc. (NASDAQ:AAPL) also recently hired Masimo’s Michael O’Reilly, who was the company’s former executive vice president and chief medical officer. He’s an MD who also is a professor of anesthesiology and perioperative care at the University of California in Irvine and adjunct associate professor of anesthesiology at University of Michigan.
Apple Insider added in a recent article, “The latest hiring is of particular interest because Apple is rumored to be working on a new wrist-worn accessory that would allow users to easily track fitness and health data. It’s expected to be a peripheral that would connect to Apple Inc. (NASDAQ:AAPL)’s existing ecosystem of devices, and potentially utilize a dedicated iPhone application for user feedback. Well-connected analyst Ming-Chi Kuo of KGI Securities was first to report last May that Apple’s so-called “iWatch” would focus on biometric feedback and deep integration with existing iOS devices. He also believes the device will sport a “secure user identification mechanism.”
We can expect big things in the near future from Apple!